XML 54 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Collaboration Agreements and Revenues - Deferred Revenue - Additional Information (Detail) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Deferred revenue $ 5,256 $ 2,147
Product Revenue, Net [Member] | Beijing Falikang Pharmaceutical Co Ltd    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Reductions to gross accounts receivable 10,100  
AstraZeneca Agreements [Member]    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Deferred revenue 149,759 $ 137,338
AstraZeneca Agreements [Member] | China [Member]    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Deferred revenue $ 6,300